Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Family Practice
|
June 17, 2011
Recruiting end-of-life cancer patients in the Netherlands for a study on suffering and euthanasia requests
C D M Ruijs, J Goedhart, A J F M Kerkhof, et al.
BMC Cell Biology
|
June 9, 2018
The C-terminus of the oncoprotein TGAT is necessary for plasma membrane association and efficient RhoA-mediated signaling
J van Unen, D Botman, T Yin, et al.
Crisis
|
September 24, 2011
Understanding why older people develop a wish to die: a qualitative interview study
M L Rurup, H R W Pasman, J Goedhart, et al.
European Journal of Pediatrics
|
October 18, 2019
Marfan syndrome in adolescence: adolescents' perspectives on (physical) functioning, disability, contextual factors and support needs
Jessica Warnink-Kavelaars, Anita Beelen, Tine M H J Goedhart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 8, 2022
Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic-guided dosing of replacement therapy in haemophilia A?
Tine M H J Goedhart, Laura H Bukkems, Iris van Moort, et al.
British Journal of Clinical Pharmacology
|
August 11, 2023
A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia B
Sjoerd F Koopman, Tine M H J Goedhart, Laura H Bukkems, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
March 14, 2022
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
Tine M H J Goedhart, Laura H Bukkems, Michiel Coppens, et al.
Research and Practice in Thrombosis and Haemostasis
|
May 1, 2024
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B
Tine M H J Goedhart, Laura H Bukkems, Anne-Fleur Zwagemaker, et al.
Thrombosis and Haemostasis
|
May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A Patients
Laura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Family Practice
|
June 17, 2011
Recruiting end-of-life cancer patients in the Netherlands for a study on suffering and euthanasia requests
C D M Ruijs, J Goedhart, A J F M Kerkhof, et al.
BMC Cell Biology
|
June 9, 2018
The C-terminus of the oncoprotein TGAT is necessary for plasma membrane association and efficient RhoA-mediated signaling
J van Unen, D Botman, T Yin, et al.
Crisis
|
September 24, 2011
Understanding why older people develop a wish to die: a qualitative interview study
M L Rurup, H R W Pasman, J Goedhart, et al.
European Journal of Pediatrics
|
October 18, 2019
Marfan syndrome in adolescence: adolescents' perspectives on (physical) functioning, disability, contextual factors and support needs
Jessica Warnink-Kavelaars, Anita Beelen, Tine M H J Goedhart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 8, 2022
Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic-guided dosing of replacement therapy in haemophilia A?
Tine M H J Goedhart, Laura H Bukkems, Iris van Moort, et al.
British Journal of Clinical Pharmacology
|
August 11, 2023
A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia B
Sjoerd F Koopman, Tine M H J Goedhart, Laura H Bukkems, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
March 14, 2022
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
Tine M H J Goedhart, Laura H Bukkems, Michiel Coppens, et al.
Research and Practice in Thrombosis and Haemostasis
|
May 1, 2024
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B
Tine M H J Goedhart, Laura H Bukkems, Anne-Fleur Zwagemaker, et al.
Thrombosis and Haemostasis
|
May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A Patients
Laura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.
Page
of 2